Clinical trial
EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial: An European Registry
NCT04598308 is registered in ClinicalTrials.gov with Catharina Ziekenhuis Eindhoven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EUROpean Coronary microCirculatory Resistance and Absolute Flow Trial: An European Registry
- Lead sponsor
- Catharina Ziekenhuis Eindhoven
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2020
- Completion date
- October 1, 2023
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary vasospasm, microvascular angina, microvascular coronary artery disease, microvascular resistance